Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-19

Clinical Trial Update: Phase I Cetuximab and Concurrent Radio-chemotherapy [Phase 1]

View source ↗

Summary

Phase I trial evaluating cetuximab with concurrent radiochemotherapy in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED